Andres Redondo

19PUBLICATIONS
106CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursMolecular targetsComparative language studies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Dec 22, 2025
Improving the performance of polymerase chain reaction for microsatellite instability testing in endometrial cancer.

Marta Mendiola, Victoria Heredia-Soto, Amparo Baillo

|Dec 03, 2025
Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III Trial.

Philipp Harter, Frederik Marmé, Andrés Redondo

|Nov 13, 2025
The Proteomic Landscape of CTNNB1 Mutated Low-Grade Early-Stage Endometrial Carcinomas.

Alvaro Lopez-Janeiro, Emilia Brizzi, Ignacio Ruz-Caracuel

|Oct 16, 2025
Diagnosis and Therapy of Soft Tissue Sarcomas: Spanish Group for Research in Sarcomas (GEIS) Guidelines.

Maria Angeles Vaz-Salgado, Claudia Valverde-Morales, Rosa Alvarez

|Jul 01, 2025
Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma: the Asian cohort of the AtTEnd/ENGOT-EN7 trial.

Kenichi Harano, Roldano Fossati, Beatriz Pardo

|Sep 16, 2024
Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial.

David S Moura, Jesus M Lopez-Marti, Iva Benesova

Pageof 4

Frequent Collaborators

6 joint publications

David Hardisson

5 joint publications

Ignacio Ruz-Caracuel

4 joint publications

Alberto Berjón

4 joint publications

Alberto Peláez-García